Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2019-10-03 2019-10-10 95370
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
PORTIA 28 0.03MG 0.15MG TABLET Resolved 2019-09-26 2019-10-10 94874
PORTIA 21 0.03MG 0.15MG TABLET Resolved 2019-09-26 2019-10-10 94870
TEVA-LEVOCARBIDOPA 25MG 100MG TABLET Resolved 2019-09-26 2019-10-10 94864
TEVA-LACOSAMIDE 150MG TABLET Resolved 2019-10-03 2019-10-10 95387
PEMETREXED DISODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-10-17 93140
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
ACT RIZATRIPTAN 10MG TABLET Resolved 2019-09-05 2019-10-17 93169
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Resolved 2019-08-22 2019-10-24 92229
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
APRI 28 0.15MG 0.03MG TABLET Resolved 2019-08-29 2019-10-24 92660
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92666
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92669
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92678
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92681
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2019-10-17 2019-10-26 96730
AVIANE 28 20MCG 100MCG TABLET Resolved 2019-09-26 2019-11-01 94828

Showing 401 to 420 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81307
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-FAMOTIDINE 20MG TABLET Discontinued 2019-04-11 2019-04-11 81371
TEVA-PREDNISONE 5MG TABLET Discontinued 2019-04-11 2019-04-11 81376
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81381
TEVA-LAMOTRIGINE 25MG TABLET Discontinued 2019-04-11 2019-04-11 81388
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393

Showing 101 to 120 of 250